# The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathways

**Authors:** Sofie Van Rossom, Ken Op de Beeck, Vesna Hristovska, Joris Winderickx, Guy Van Camp

PMC · DOI: 10.3389/fncel.2015.00231 · Frontiers in Cellular Neuroscience · 2015-07-16

## TL;DR

This study shows how a gene linked to hearing loss and cancer causes cell death through mitochondrial and MAPK pathways.

## Contribution

The study reveals novel mechanisms of programmed cell death induced by DFNA5 mutations in both human and yeast models.

## Key findings

- Mutant DFNA5 induces programmed cell death in human cell lines and yeast.
- In yeast, mitochondrial and energy metabolism pathways are up-regulated.
- In human cells, MAP kinase pathways are up-regulated and partially reversible with inhibition.

## Abstract

Cell death exists in many different forms. Some are accidental, but most of them have some kind of regulation and are called programmed cell death. Programmed cell death (PCD) is a very diverse and complex mechanism and must be tightly regulated. This study investigated PCD induced by DFNA5, a gene responsible for autosomal dominant hearing loss (HL) and a tumor suppressor gene (TSG) involved in frequent forms of cancer. Mutations in DFNA5 lead to exon 8 skipping and result in HL in several families. Expression of mutant DFNA5, a cDNA construct where exon 8 is deleted, was linked to PCD both in human cell lines and in Saccharomyces cerevisiae. To further investigate the cell death mechanism induced by mutant DFNA5, we performed a microarray study in both models. We used wild-type DFNA5, which does not induce cell death, as a reference. Our data showed that the yeast pathways related to mitochondrial ATP-coupled electron transport chain, oxidative phosphorylation and energy metabolism were up-regulated, while in human cell lines, MAP kinase-related activity was up-regulated. Inhibition of this pathway was able to partially attenuate the resulting cell death induced by mutant DFNA5 in human cell lines. In yeast, the association with mitochondria was demonstrated by up-regulation of several cytochrome c oxidase (COX) genes involved in the cellular oxidative stress production. Both models show a down-regulation of protein sorting- and folding-related mechanisms suggesting an additional role for the endoplasmic reticulum (ER). The exact relationship between ER and mitochondria in DFNA5-induced cell death remains unknown at this moment, but these results suggest a potential link between the two.

## Linked entities

- **Genes:** GSDME (gasdermin E) [NCBI Gene 1687]
- **Diseases:** hearing loss (MONDO:0005365), cancer (MONDO:0004992)
- **Species:** Saccharomyces cerevisiae (taxon 4932)

## Full-text entities

- **Genes:** MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, MPV17 (mitochondrial inner membrane protein MPV17) [NCBI Gene 4358] {aka CMT2EE, MTDPS6, SYM1}, RO60 (Ro60, Y RNA binding protein) [NCBI Gene 6738] {aka RORNP, SSA2, TROVE2}, AI5_ALPHA (intron-encoded DNA endonuclease aI5 alpha) [NCBI Gene 854597], ATF3 (activating transcription factor 3) [NCBI Gene 467], EPB42 (erythrocyte membrane protein band 4.2) [NCBI Gene 2038] {aka PA, SPH5}, VSIG2 (V-set and immunoglobulin domain containing 2) [NCBI Gene 23584] {aka 2210413P10Rik, CTH, CTXL}, COX10 (cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10) [NCBI Gene 1352] {aka MC4DN3}, SLC25A6 (solute carrier family 25 member 6) [NCBI Gene 293] {aka AAC3, ANT, ANT 2, ANT 3, ANT3, ANT3Y}, RNR1 (s-rRNA) [NCBI Gene 4549] {aka MTRNR1}, TM7SF2 (transmembrane 7 superfamily member 2) [NCBI Gene 7108] {aka ANG1, C14SR, DHCR14A, NET47}, CHMP1B (charged multivesicular body protein 1B) [NCBI Gene 57132] {aka C10orf2, C18-ORF2, C18orf2, CHMP1.5, Vps46-2, Vps46B}, TPI1 (triosephosphate isomerase 1) [NCBI Gene 7167] {aka HEL-S-49, TIM, TPI, TPID}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, CLEC2D (C-type lectin domain family 2 member D) [NCBI Gene 29121] {aka CLAX, LLT1, OCIL}, DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, COX8A (cytochrome c oxidase subunit 8A) [NCBI Gene 1351] {aka COX, COX8, COX8-2, COX8L, MC4DN15, VIII}, ETV4 (ETS variant transcription factor 4) [NCBI Gene 2118] {aka E1A-F, E1AF, PEA3, PEAS3}, CDC19 (pyruvate kinase CDC19) [NCBI Gene 851193] {aka PYK1}, ATP8A2 (ATPase phospholipid transporting 8A2) [NCBI Gene 51761] {aka ATP, ATPIB, CAMRQ4, IB, ML-1}, LRP5L (LDL receptor related protein 5 like (pseudogene)) [NCBI Gene 91355], GUSBP2 (GUSB pseudogene 2) [NCBI Gene 387036] {aka GUSBL1, SMA3-L, SMAC3L, SMAC3L2, b55C20.1, bA239L20.1}, ERAP2 (endoplasmic reticulum aminopeptidase 2) [NCBI Gene 64167] {aka L-RAP, LRAP}, FIS1 (fission, mitochondrial 1) [NCBI Gene 51024] {aka CGI-135, TTC11}, DNAJB1 (DnaJ heat shock protein family (Hsp40) member B1) [NCBI Gene 3337] {aka HSPF1, Hdj1, Hsp40, RSPH16B, Sis1}, ZNF256 (zinc finger protein 256) [NCBI Gene 10172] {aka BMZF-3, BMZF3}, SPRY2 (sprouty RTK signaling antagonist 2) [NCBI Gene 10253] {aka IGAN3, hSPRY2}, MSMO1 (methylsterol monooxygenase 1) [NCBI Gene 6307] {aka DESP4, ERG25, MCCPD, SC4MOL}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, MAL32 (alpha-glucosidase MAL32) [NCBI Gene 852602], MAL12 (alpha-glucosidase MAL12) [NCBI Gene 853209], YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) [NCBI Gene 7534] {aka 14-3-3-zeta, HEL-S-3, HEL-S-93, HEL4, KCIP-1, POPCHAS}, ETV5 (ETS variant transcription factor 5) [NCBI Gene 2119] {aka ERM}, VPS33B (VPS33B late endosome and lysosome associated) [NCBI Gene 26276] {aka KDIDAR, PFIC12}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, ZCCHC12 (zinc finger CCHC-type containing 12) [NCBI Gene 170261] {aka PNMA7A, SIZN, SIZN1}, TRNS1 (tRNA-Ser) [NCBI Gene 4574] {aka MTTS1}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, DDIT4 (DNA damage inducible transcript 4) [NCBI Gene 54541] {aka Dig2, REDD-1, REDD1}, COX10 (protoheme IX farnesyltransferase) [NCBI Gene 855931], TRIM9 (tripartite motif containing 9) [NCBI Gene 114088] {aka RNF91, SPRING}, PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1) [NCBI Gene 5366] {aka APR, NOXA}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, DIABLO (diablo IAP-binding mitochondrial protein) [NCBI Gene 56616] {aka DFNA64, SMAC}, RPL13A (ribosomal protein L13a) [NCBI Gene 23521] {aka L13A, TSTA1, uL13}, BCS1L (BCS1 ubiquinol-cytochrome c reductase complex chaperone) [NCBI Gene 617] {aka BCS, BCS1, BJS, FLNMS, GRACILE, Hs.6719}, MND1 (meiotic nuclear divisions 1) [NCBI Gene 84057] {aka GAJ}, IFI44 (interferon induced protein 44) [NCBI Gene 10561] {aka MTAP44, TLDC5, p44}, OPA1 (OPA1 mitochondrial dynamin like GTPase) [NCBI Gene 4976] {aka BERHS, MGM1, MTDPS14, MTDPS14A, MTDPS14B, NPG}, MAFF (MAF bZIP transcription factor F) [NCBI Gene 23764] {aka U-MAF, hMafF}, CCNA1 (cyclin A1) [NCBI Gene 8900] {aka CT146}, SNORD15B (small nucleolar RNA, C/D box 15B) [NCBI Gene 114599] {aka RNU15B, U15B}, EGR1 (early growth response 1) [NCBI Gene 1958] {aka AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268}, EPHA2 (EPH receptor A2) [NCBI Gene 1969] {aka ARCC2, CTPA, CTPP1, CTRCT6, ECK}, COX3 (cytochrome c oxidase subunit III) [NCBI Gene 4514] {aka COIII, MTCO3}, GNPDA1 (glucosamine-6-phosphate deaminase 1) [NCBI Gene 10007] {aka GNP1, GNPDA, GNPI, GPI, HLN}, ENO2 (enolase 2) [NCBI Gene 2026] {aka HEL-S-279, NSE}, HSPA6 (heat shock protein family A (Hsp70) member 6) [NCBI Gene 3310] {aka HSP70B'}, LRATD2 (LRAT domain containing 2) [NCBI Gene 157638] {aka BCMP101, FAM84B, NSE2}
- **Diseases:** tinnitus (MESH:D014012), ARHI (MESH:C567305), PCD (MESH:D003643), toxicity (MESH:D064420), Mitochondria (MESH:C564971), cochlear dysfunction (MESH:D000160), cancer (MESH:D009369), deafness (MESH:D003638), mitochondrial damage (MESH:D028361), NIHL (MESH:D006317), Ototoxicity (MESH:D006311), sensorineural HL (MESH:D006319), mitochondrial fragmentation (MESH:D012892), pain (MESH:D010146), breast, colorectal, hepatocellular, and gastric cancer (MESH:D013274), inflammatory (MESH:D007249), non-syndromic HL (MESH:C537845), HL (MESH:D034381)
- **Chemicals:** fatty acids (MESH:D005227), propidium iodide (MESH:D011419), glucose (MESH:D005947), L-glutamine (MESH:D005973), EDTA (MESH:D004492), SDS (MESH:D012967), NP-40 (MESH:C010615), (ergo)sterols (MESH:D004875), Ca2+ (-), SP600125 (MESH:C432165), NaCl (MESH:D012965), ATP (MESH:D000255), maltose (MESH:D008320), platinum (MESH:D010984), penicillin (MESH:D010406), (phyto)steroids (MESH:D010840), ADP (MESH:D000244), sucrose (MESH:D013395), oligosaccharide (MESH:D009844), cholesterol (MESH:D002784), monosaccharide (MESH:D009005), pentose phosphate (MESH:D010428), streptomycin (MESH:D013307), sugar (MESH:D000073893), sodium deoxycholate (MESH:D003840), lipid (MESH:D008055), Cy5 (MESH:C085321), aminoglycoside (MESH:D000617), lipofectamine (MESH:C086724), SYBR Green (MESH:C098022), ROS (MESH:D017382)
- **Species:** Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** V16A, A1555G, A1555G, IVS8+4 A>G
- **Cell lines:** 293T — Homo sapiens (Human), Transformed cell line (CVCL_0063)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4504148/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4504148/full.md

## References

94 references — full list in the complete paper: https://tomesphere.com/paper/PMC4504148/full.md

---
Source: https://tomesphere.com/paper/PMC4504148